Venture Capital · New York (United States) · Founded 2012
Casdin Capital invests in all aspects of the life sciences revolution, partnering with companies across Healthcare, Biotechnology, Synthetic Biology, and Technology. Their investment strategy focuses on big markets, great ideas, strong teams, and a long-term perspective. They aim to create value and open new opportunities through patience and strong relationships.
Series A, Series B, Series C
BioTech, Deep Tech, Healthcare
23andMe, 4D Molecular Therapeutics, 908 devices, A2 Biotherapeutics, AbSci, Adaptive Biotechnologies, Affinia, Alector, Aledade, AmplifyBio